Market Research Blog

During the forecast period, the pathology imaging systems market is expected to grow at a CAGR of 10.36%, reaching a pathology imaging systems market share of US$ 2603.74 Million in 2032, up from US$ 971.59 Million in 2022.

Pathology Imaging Systems Market: Drivers & Restraints

Rising cancer incidences, increasing demand of improved diagnostic techniques, increasing spending on healthcare, government funding, rising R&D efforts are some of the factors driving the overall market of pathology imaging systems. Popularity of pathology imaging systems in hospitals, diagnostic centers and research organizations are surging the market. Rise in the tele-pathology trend also fuels the market growth. High capital investment and maintenance cost curbs the growth. Less number of highly skilled operators, stringent regulatory compliance, sampling error also limits its expansion. 

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4125

Pathology imaging system uses the latest technology of scanners and software for digitizing the slides for pathological examinations. It has replaced the traditional pathology workflow of slides and microscope. By digitizing slides, pathologists are able to examine high resolution digital images of the pathology workflow with the help of precision tools. Using these system, images can be stored in a computer, send to another person and thus improve the pathology workflow. This technology helps in more precise diagnosis by facilitating accurate and timely diagnosis, patient-centric information, eliminate time consuming analog tasks and enhancing the overall lab performance.

These systems helped the patients to receive better care and transforming healthcare organizations. With the growing cases of chronic diseases like cancer, it has become important to visualize each and every molecular aspect. Pathology imaging systems have finds its use in all the phases of drug discovery, education, clinical and research and thus has made the anatomic pathology workflow more efficient and effective.These pathology imaging systems are instinctive solution that benefits various pathologists, healthcare professionals and entire healthcare enterprise. Shift from glass to the digital system opens the way for next generation tools such as advanced image analysis & algorithms. It also helps in new data integration like genomic and molecular testing thus leading to precise and personalized treatment plans.Pathology Imaging Systems Market: Overview 

A large number of key players in the market and established brands increasing the competition. New technologies in this sector are cutting edge for the market. Strategic mergers and partnerships between companies and academic institutions are also booming the growth. Significant technology gains led to the adoption of innovative imaging systems technology in pathology. Rising demand by various end users because of increasing adoption of this technology increases its market. Diagnosis applications is accounted to be the largest segment in terms of revenue generating.

Pathology Imaging Systems Market: Region-wise Outlook

With high technological advancements, and research activities in the molecular diagnostics, North America dominates the world market followed by Western European nations. Quality diagnostics, favourable reimbursement scenario, government funding, established players in the market, availability of trained technicians in these regions creates the established market for pathology imaging systems. . Japan is expected to be the next lucrative market for digital pathology companies. With respect to growth rate, Asia Pacific is leading because of growing economies, increasing molecular research activities, increasing patient pool and improving healthcare opportunities.

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4125

Pathology Imaging Systems Market: Key Players

Some of the key players for Pathology Imaging Systems Market include GE Healthcare, Leica Biosystems, Perkin Elmer, Siemens, Olympus Corporation, Philips Healthcare, Sakura Finetek, DigiPath, Carl Zeiss Meditec AG, Hamamatsu Photonics, 3D-Histech Ltd and others.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-4125

Pathology Imaging Systems Market: Segmentation 

 Segmentation by Product Type

• Imaging Systems
• Accessories and software
• Services

Segmentation by Application

• Clinical Diagnosis
• Academic Research

Segmentation by End Users

• Hospitals
• Diagnostic Laboratories
• Research Organizations

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

X-Ray Aprons Market Overview

X-ray aprons are also known as lead aprons or leaded aprons used for protection against harmful radiations. It is a type of protective clothing that acts as the radiation shield. Lead X-ray aprons are used to reduce exposure of radiation to both patient and personnel.

X-ray aprons are made up of thin rubber sheet at the exterior. X-ray aprons are used along with lead gloves and lead glasses. The main purpose of using X-ray apron is to minimize the exposure of harmful X-ray to vital organs. Prolonged exposure to X-ray has been linked to increasing chances of developing cancer. X-ray aprons protect vital organs from harmful radiations exposed during medical imaging processes such as radiography, computed tomography, fluoroscopy and others.

X-ray aprons also help to protect reproductive organs. Protective reproductive organ is important as radiation may cause changes in the DNA of egg cell and sperm which leads to genetic defects in the offspring of the patients. According to researchers, the thyroid gland is most vulnerable to X-rays. Care should be taken to protect or cover thyroid gland using X-ray aprons or thyroid collars during dental radiographs.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7309

X-Ray Aprons Market: Drivers & Restraints 

Increase in the number of medical imaging processes drives the global X-ray aprons market. Other factors such as rise in geriatric population and increase in awareness among the people also expanded the growth of global X-ray aprons market in the stated forecast period. Increase in the number of diagnostic imaging centers in developed and developing countries also boost the market growth of X-ray aprons.

Technological advancement and increasing prevalence of diseases that requires medical imaging also escalate the market growth of X-ray aprons. High cost and lack of reimbursement policies restrain the growth of X-ray aprons in the stated forecast period. Heaviness associated with the lead X-ray aprons has shown the detrimental effect on the health of the wearer, particularly spinal injuries also decline the growth of X-ray aprons market.

Vascular Testing Devices Market Overview

Vascular disease is of two type viz. peripheral artery disease (PAD) and chronic venous insufficiency (CVI). Vascular disease can be life-threatening due to incorrect and delay diagnosis. Vascular testing devices encompass a broad range of equipment and expertise for proof of principle.

Vascular testing is also known as non-invasive vascular testing in which various technology based devices are utilized to evaluate the blood vessels. The evaluation and testing of the blood vessels can be done at the rest time or at the time of the exercise. Vascular testing is generally painless and determine the disease location and severity.

Vascular testing devices are comes with the advanced features such as digital dashboard and online interface with the remotely located facility centers. These devices also come with the specifications such as LAN/WAN and DICOM/PACS compatibility.

The increasing incidence of death and other complications due to stroke and myocardial infarction amongst those with silent asymptomatic peripheral vascular disease is the key growth factor boost the use of vascular testing devices for diagnosis purpose.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6884

Vascular Testing Devices Market: Drivers & Restraints

The global vascular testing devices market is expected to register a significant CAGR over a forecast period. The increasing prevalence of vascular diseases and disorders, lifestyle diseases is the key factor anticipated to propel the demand for vascular testing devices and drives the growth of the global vascular testing devices market.

The technically advanced vascular testing devices allows great access to vascular disease testing in particularly non-interventional settings, which helps to diagnose more patients with disease before disease progresses to a potentially critical stage. The availability of portable and easily operable testing devices for vascular diseases is also expected to be the major factor drives the growth of the global vascular testing devices market over the forecast period.

The vascular devices also work on the telemedicine technology and send test data to a remotely located specialist for the online interpretation which anticipated to surge the demand for vascular testing devices over the long run.

However, the lack of expertise and physicians to operate vascular testing devices and to interpret the test data may restrain the growth of the global vascular testing devices market over the forecast period. The higher cost of set up of the vascular testing lab and devices may hamper the demand of vascular testing devices and restrain the growth of the global vascular testing devices market over the long run.

Transcutaneous Bilirubinometers Market: Overview

Transcutaneous Bilirubinometers is a non-invasive method and is based on the principle of multi wavelength spectral reflectance from the bilirubin staining in the skin. The accuracy of the instrument may be affected by variation of skin pigmentation and its thickness.

There are two treatment options for treating hyperbilirubinemia one through phototherapy and other through pharmacological treatment. Phototherapy is further sub dived as intensive, conventional and exchange transfusion. Pharmacological treatment is divided as phenobarbitone, intravenous immunoglobulins (IVIG), and metalloporphyrins and follow up remedies.

Transcutaneous Bilirubinometers Market Overview

Hyperbilirubinemia or jaundice is a multifactorial condition in new-borns with several symptoms. Physiological jaundice is visible but there is also pathological jaundice which is not visible whose prevalence is more in few countries. When the total bilirubin level rise above 95th percentile for a given age group, it is considered as hyperbilirubinemia.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5968

While bilirubin in normal level act as an antioxidant to the biological system, the presence of it towards the higher site may lead of the central nervous system damage leading to the neurological and behavioural impairment. There are several types of bilirubinaemia which are pathological, physiological, and haemolytic and jaundice due to breastfeeding.

Haemolytic bilirubinaemia is further subdivided into ABO blood group incompatibility, Rh factor incompatibility and jaundice associated with Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Transcutaneous Bilirubinometers Market: Drivers and Restraints

According to the National Neonatal-Perinatal Database (NNPD), the incidence of hyperbilirubinemia is 3.3% while the morbidity occurrence due to it is 22.1%. In neonates, the pale yellow color first starts from the face and the proceeds to the body and the extremities. The incidence of jaundice is more in the low and middle income countries.

For instance out of the 1.1 million babies that are diagnosed for jaundice majority of them are in the sub-Saharan Africa and South Asia. Moreover, the launch of upgraded products and technology towards the detection of bilirubin level through a non-invasive way is being adopted by various industry players.

Rapid Test Cards Market Overview

Rapid test card is a medical diagnostic test card that qualitatively detects the presence of pathogens in a sample (blood/serum). Rapid test cards are widely used in clinical settings as they offer quick results. Quick tests are utilized as a part of an assortment of purpose of care-settings including homes to essential care centers or emergency rooms.

Some of the common rapid test cards available in the market are Hepatitis test cards, pregnancy test card, HIV test, HCV test, syphilis card/strip test, troponin-I test, and malaria/dengue test cards. Owing to advances in rapid testing technology, today, these tests are widely used in clinics and hospitals.

Rapid test cards usually encompass the interface of an immovable reagent of any of the target antigen or antibody that is associated to certain category of detector which later on reacts with the loaded patient sample. Rapid test cards enable a rapid screening of a possibly affected population, and can be applied for various applications to determine the complications leading for infections or pregnancy.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5042

Rapid Test Cards Market: Drivers and Restraints

The development of the rapid test cards market during the forecast period is primarily determined by the expanded usage of rapid test cards mainly in the cases of pregnancy, HIV, malaria, dengue, chikungunya, and leishmanial. Overall growth can be attributed to its low-cost, ease of use, sensitivity, and stability at high temperatures.

Rapid test cards are most favoured for quick and precise outcomes. Rising infection rate from malaria, dengue and other viral infections in developing countries is creating sustained demand for rapid test cards market. The usability of rapid test cards has impelled the appropriation of different test units to differentiate the alteration between various pathogens and other infectious diseases.

However, nonappearance of conclusive diagnostic testing, inaccuracy in readings in few rapid test cards in the domestic market may hamper the overall growth & development of the rapid test card market over the forecast period. Also, few of the high production costs of rapid test cards with high end technology in developing markets may act as a limitation to the overall growth in developing countries.

[300+ Pages Report] As per Future Market Insights’ latest revised industry analysis, the global cancer gene therapy market is projected to expand at a 10.1% CAGR over the forecast period, with the market size reaching US$ 5.3 Bn in 2032.

Gene therapy is a field of medicine that aims to cure or greatly improve the treatment of diseases that have few or no treatment options. Advanced-stage cancer and hematological illnesses make up a large share of gene therapy candidates. In addition to this, gene therapy is frequently used to treat rare or inherited diseases.

While gene therapy research is still in its early stages, firms are increasingly investing in the technology. A handful of products have recently received approval outside of Canada or are in the final stages of clinical trials.

Request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14971

Gene therapy is currently extremely expensive. Multi-stakeholder discussions about pricing and reimbursement management for these goods are required. To provide accessibility and quality of care, specialized manufacturing facilities, care centers, and doctors skilled to undertake specific procedures for such therapies are required.

The growth in the cancer gene therapy market is reliant on increasing awareness about health, the growing incidence of cancer, and the latest advancements in cancer gene therapy.

“Rising awareness regarding cancer gene therapy across emerging economies, along with favorable healthcare reimbursement plans in various countries will create opportunities for growth in the market over the forecast period,” says an FMI analyst.

Key Players :

• Merck KGaA
• Novartis AG
• AstraZeneca Plc.
• BIOCAD
• Crinetics Pharmaceuticals, Inc.
• EffRx Pharmaceuticals S.A.
• Euroscreen S.A.
• Vicore Pharma AB
• Amgen
• Bristol-Myers Squibb
• Cell Genesys Inc.
• Adaptimmune Therapeutics plc.
• Achieve Life Science Inc.
• BioCanCell Ltd.
• Genelux Corporation
• Advantagene Inc.,
• GenVec Inc.
• GlaxoSmithKline PLC
• Amgen Inc.

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-14971

Key Takeaways:

• Based on therapy, the oncolytic virotherapy segment accounted for about 3% of the total market share in 2021.
• In terms of indication, sales in the breast cancer segment are forecast to grow at a CAGR of 7% in the forecast period.
• By service provider, demand in the hospitals segment will grow at a 9.3% CAGR through 2032.
• The U.S. will dominate the North America cancer gene therapy market over the forecast period.
• China will emerge as a lucrative pocket, accounting for 32.3% of the East Asia cancer gene therapy market share over the assessment period.
• Demand in Germany is expected to increase at a 11.9% CAGR over the assessment period.

Competition Landscape

Acquisitions, partnerships, geographical recognition, and product launches are the key strategies adopted by leading players to increase the consumer base. For instance:

• In March 2022, Novartis and Carisma Therapeutics agreed to collaborate on the development of HER 2 targeted CAR-M cell therapy.
• A2 Biotherapeutics and Merck announced a collaboration in December 2020 to develop allogeneic cell therapy for solid tumor cancers.

Want More Insights

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global cancer gene therapy market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the cancer gene therapy market segment based on therapy – (gene induced immunotherapy, oncolytic virotherapy, gene transfer, and others), by indication (breast cancer, ovarian cancer, liver cancer, pancreatic cancer, lung cancer, and prostate cancer), by service provider (hospitals, clinical research laboratory, and oncology institutes), across seven major regions.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14971

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

By Therapy:

• Gene Induced Immunotherapy
• Oncolytic Virotherapy
• Gene Transfer
• Others

By Indication:

• Breast Cancer
• Ovarian Cancer
• Liver Cancer
• Pancreatic Cancer
• Lung Cancer
• Prostate Cancer

By Service Provider:

• Hospitals
• Clinical Research Laboratory
• Oncology institutes

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[250 Pages Report] According to Future Market Insight’s latest analysis, the global home rehabilitation services market was valued at over US$ 84.1 Bn in 2021 and is expected to exhibit a CAGR of close to 4.8% over the forecast period (2022-2032).

The home rehabilitation services market is witnessing a high demand owing to the rising prevalence of chronic disease, surge in the population with disability and the increase in the number of baby boomers.

According to the World Health Organization, more than 1 billion people in the world live with disability. Some health conditions associated with a disability will result in poor healthcare needs. In most parts of the world, people with disabilities face extreme barriers while accessing health and rehabilitation services.

It is critical for home care patients to not only identify each subject’s stimuli, incorporate them into everyday life, and increase the number of times in training, but also to observe tenderly and attend with sympathy. Such a strategy would alleviate a subject’s worry while also providing motivation and peace of mind.

Request a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14870

The increased awareness of the benefits of home rehabilitation services among physicians and patients and rising trend of home healthcare government support and initiative and the increasing adoption of telerehabilitation and e-health will provide even more attractive potential for market expansion.

“Increasing popularity of telehealth services, along with growing demand for ortho rehabilitation will augment the growth in the market over the assessment period,” says an FMI analyst.

Key Takeaways:

• Sales in the ortho rehabilitation segment are forecast to increase at a 5% CAGR over the assessment period.
• The U.S. will dominate the North America home rehabilitation services market and held 92.8% of the total market share in 2021.
• Demand for home rehabilitation services in China will grow at a 5% CAGR through 2032.
• Australia will emerge as a lucrative pocket, with demand growing at a 4.6% CAGR over the forecast period.

Competition Landscape

Key service providers are collaborating at all levels of the health system to develop technical, policy, and research capability, as well as increase political commitment and inspire leadership.

Various manufacturers are also utilising modern technologies and supporting simple, low-cost service delivery methods to provide access to rehabilitation in the home and community, which is where it is most needed. For instance:

• In late 2020, ReLAB-HS launched a five-year initiative adapted to satisfy the growing need for physical rehabilitation services in low- and middle-income countries.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14870

Key Market Segments Covered in Home Rehabilitation Services Industry Research

By Service Type:

• Ortho Rehabilitation
• Neuro Rehabilitation
• Cardiopulmonary Rehabilitation
• Geriatric Rehabilitation
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Which Factors are Restraining the Demand for Home Rehabilitation Services?

Despite the growing scope of services in the developed countries, home tele-rehabilitation services tend to face many challenges across developing economies. Factors such as the lack of physician skills required in e-health, apprehensions associated with data privacy, and the dearth of national e-health policies, will hinder the growth in the home rehabilitation services market.

Most of the healthcare professionals are not well acquainted with the latest information technologies, and also find it difficult to handle modern gadgets. There is a lack of telemedicine experts in many developing countries, which can hamper demand for home rehabilitation services.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14870

More Insights into Home Rehabilitation Services Market Report

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032.

The global home rehabilitation services market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the home rehabilitation services market segment based on   By services– (ortho rehabilitation, neuro rehabilitation, cardiopulmonary rehabilitation, geriatric rehabilitation, and others), and across seven major regions.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.

Contact:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs